Device for the subcutaneous administration of pre-polymerized hydrogels
TECHNOLOGY NUMBER: 2025-031
OVERVIEW
Delivery device for subcutaneous placement of pre-polymerized hydrogels and large implants.- High-precision subcutaneous delivery without tearing skin, rupturing fragile hydrogel capsules, or displacing implants upon trocar withdrawal.
- Subcutaneous deployment of immunoisolated encapsulated ovarian allografts, drug delivery vehicles, continuous glucose monitors, and large implants.
BACKGROUND
Subcutaneous administration of large biological implants, pre-polymerized hydrogels, and encapsulated therapies often presents structural and mechanical delivery challenges. Existing delivery approaches primarily rely on standard insertion devices, laparoscopic trocars, or specialized tools designed for rigid implants like birth control rods, puberty blockers, and continuous glucose monitors. However, these traditional tools are not optimized for large, delicate, or flexible hydrogel structures, which can be up to 10mm in diameter. Standard insertion methods frequently risk tearing the surrounding skin tissue, causing traumatic damage to the subcutaneous fat layers, or exerting excess shearing forces that rupture sensitive biomaterial capsules during placement. Furthermore, withdrawing conventional insertion devices often results in unwanted displacement or dragging of the implant from the targeted site. Consequently, there is a clear need for a specialized delivery system that can create a secure subcutaneous pocket, safely position large fragile hydrogels, and withdraw cleanly without displacing the implant or causing tissue trauma.
INNOVATION
The proposed technology consists of a novel two-part trocar specifically engineered for the precise subcutaneous delivery of pre-polymerized hydrogels and implants up to 10mm in diameter. The primary component functions as a protective housing that bluntly dissects toward the target site and features specialized jaws that open a pocket within the subcutaneous fat. The secondary component acts as a plunger, advancing the hydrogel safely into the newly created fat pocket. Once deployed, the plunger and primary housing are withdrawn while leaving the intact hydrogel completely undisturbed in the subcutaneous tissue. This mechanism prevents skin tears, avoids capsule rupture, and eliminates implant displacement during tool removal. The technology enables safer administration of sensitive biomaterials, including immunoisolated encapsulated ovarian allografts, drug delivery systems, and continuous glucose monitors.
ADDITIONAL INFORMATION
INTELLECTUAL PROPERTY
RELATED TECHNOLOGY
- Restoration of Ovarian Endocrine Function
- Immune Isolating Device With Improved Diffusion
- Method for analysis and selection of human ovarian tissue for grafting in an immune-isolating capsule
- Immune Training Device
- Multi-Fractional Immunoisolating Device for Human Ovarian Tissue